Basic Information
| RNALocate ID: | RLID:11003751 |
| RNA Symbol: | hsa-miR-143-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-143-5p |
| RNA ID: | miRBase:MIMAT0004599 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003750 | Exosome | Breast milk | 22211110 |
| RLID-D:11000629 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001507 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-143-5p | Large cell neuroendocrine cancer | MNDR-E-MI-14391 |
| MNDR | hsa-miR-143-5p | Medulloblastoma | MNDR-E-MI-14392 |
| MNDR | hsa-miR-143-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-14393 |
| MNDR | hsa-miR-143-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-14394 |
| MNDR | hsa-miR-143-5p | Lymphoma | MNDR-E-MI-14395 |
| MNDR | hsa-miR-143-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-14396 |
| MNDR | hsa-miR-143-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-14397 |
| MNDR | hsa-miR-143-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-14398 |
| MNDR | hsa-miR-143-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-14399 |
| MNDR | hsa-miR-143-5p | Her2-receptor positive breast cancer | MNDR-E-MI-14400 |
| MNDR | hsa-miR-143-5p | Breast cancer luminal | MNDR-E-MI-14401 |
| MNDR | hsa-miR-143-5p | Prostate cancer | MNDR-E-MI-14402 |
| MNDR | hsa-miR-143-5p | Gastric cancer | MNDR-E-MI-14403 |
| MNDR | hsa-miR-143-5p | Alzheimer disease | MNDR-E-MI-14404 |
| MNDR | hsa-miR-143-5p | Intracranial aneurysm | MNDR-E-MI-14405 |
| MNDR | hsa-miR-143-5p | Bladder cancer | MNDR-E-MI-14406 |
| MNDR | hsa-miR-143-5p | Parkinson disease | MNDR-E-MI-14407 |
| MNDR | hsa-miR-143-5p | Basal-like breast cancer | MNDR-E-MI-14408 |
| MNDR | hsa-miR-143-5p | Neuroendocrine neoplasia | MNDR-E-MI-14409 |
| MNDR | hsa-miR-143-5p | Pancreatic cancer | MNDR-E-MI-14410 |
| MNDR | hsa-miR-143-5p | Colon cancer | MNDR-E-MI-14411 |
| MNDR | hsa-miR-143-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-14412 |
| MNDR | hsa-miR-143-5p | Familial ovarian cancer | MNDR-E-MI-14413 |
| MNDR | hsa-miR-143-5p | Prostate adenocarcinoma | MNDR-E-MI-14414 |
| MNDR | hsa-miR-143-5p | Carcinoma ductal breast | MNDR-E-MI-14415 |
| MNDR | hsa-miR-143-5p | Glioblastoma | MNDR-E-MI-14416 |
| MNDR | hsa-miR-143-5p | Astrocytoma | MNDR-E-MI-14417 |
| MNDR | hsa-miR-143-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-14418 |
| MNDR | hsa-miR-143-5p | Gastric adenocarcinoma | MNDR-E-MI-14419 |
| MNDR | hsa-miR-143-5p | Cervical squamous cell carcinoma | MNDR-E-MI-14420 |
| MNDR | hsa-miR-143-5p | Lung squamous cell carcinoma | MNDR-E-MI-14421 |
| MNDR | hsa-miR-143-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-14422 |
| MNDR | hsa-miR-143-5p | Lung adenocarcinoma | MNDR-E-MI-14423 |
| MNDR | hsa-miR-143-5p | Ovarian carcinoma | MNDR-E-MI-14424 |
| MNDR | hsa-miR-143-5p | Bladder urothelial carcinoma | MNDR-E-MI-14425 |
| MNDR | hsa-miR-143-5p | Pancreatic adenocarcinoma | MNDR-E-MI-14426 |
| MNDR | hsa-miR-143-5p | Carcinoma renal cell | MNDR-E-MI-14427 |
| MNDR | hsa-miR-143-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-14428 |
| MNDR | hsa-miR-143-5p | Renal clear cell carcinoma | MNDR-E-MI-14429 |
| MNDR | hsa-miR-143-5p | Cholangiocarcinoma | MNDR-E-MI-14430 |
| MNDR | hsa-miR-143-5p | Lung small cell carcinoma | MNDR-E-MI-14431 |
| MNDR | hsa-miR-143-5p | Pulmonary arterial hypertension | MNDR-E-MI-14432 |
| MNDR | hsa-miR-143-5p | Breast invasive carcinoma | MNDR-E-MI-14433 |
| MNDR | hsa-miR-143-5p | Hepatocellular carcinoma | MNDR-E-MI-14434 |
| MNDR | hsa-miR-143-5p | Familiar ovarian carcinoma | MNDR-E-MI-14435 |
| MNDR | hsa-miR-143-5p | Malignant pleural mesothelioma | MNDR-E-MI-14436 |
| MNDR | hsa-miR-143-5p | Hodgkin lymphoma | MNDR-E-MI-14437 |
| MNDR | hsa-miR-143-5p | Colorectal cancer | MNDR-E-MI-14438 |
| MNDR | hsa-miR-143-5p | Nasopharynx carcinoma | MNDR-E-MI-14439 |
| MNDR | hsa-miR-143-5p | Nasopharyngeal cancer | MNDR-E-MI-14440 |
| MNDR | hsa-miR-143-5p | Breast cancer her3+ negative | MNDR-E-MI-14441 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CCDC6 | Homo sapiens | RR00291248 |
TOP